Signup Crypto ETF Stocks News

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TMDX - TransMedics Group ( NASDAQ:TMDX )

NEW YORK, March 19, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc.

Source: www.benzinga.com
March 19, 2025 | 22:54:24
Category: News

Treasury Expands Financial Surveillance of Cash Transactions-What About Crypto?

Beginning April 14, money services businesses in thirty zip codes across California and Texas must report cash transactions of $200 or more to the Treasury. Could it apply to crypto?

Source: decrypt.co
March 19, 2025 | 22:54:37
Category: News

ROSEN, A LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA - Neumora Therapeutics ( NASDAQ:NMRA )

NEW YORK, March 19, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neumora Therapeutics, Inc.

Source: www.benzinga.com
March 19, 2025 | 22:55:00
Category: News

SoundHound AI, Inc. Announcement: If You Have Suffered Losses in SoundHound AI, Inc. ( NASDAQ: SOUN, SOUNW ) You Are Encouraged to Contact The Rosen Law Firm About Your Rights - SoundHound AI ( NASDAQ:SOUN )

NEW YORK, March 19, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SoundHound AI, Inc.

Source: www.benzinga.com
March 19, 2025 | 22:57:03
Category: News

COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents

TORONTO, ONTARIO, March 19, 2025 ( GLOBE NEWSWIRE ) -- COSCIENS Biopharma Inc. ( NASDAQ: CSCI ) ( TSX: CSCI ) ( "COSCIENS" or the "Company" ) , a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today ...

Source: www.globenewswire.com
March 19, 2025 | 23:00:00
Category: News

JOYY Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

SINGAPORE, March 20, 2025 ( GLOBE NEWSWIRE ) -- JOYY Inc. ( NASDAQ: YY ) ( "JOYY" or the "Company" ) , a global technology company, today announced its unaudited financial results for the fourth quarter and full year of 2024.

Source: www.globenewswire.com
March 19, 2025 | 23:00:00
Category: News

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Krystal Biotech ( NASDAQ:KRYS )

Krystal Biotech KRYS has outperformed the market over the past 5 years by 18.77% on an annualized basis producing an average annual return of 37.22%. Currently, Krystal Biotech has a market capitalization of $5.45 billion.

Source: www.benzinga.com
March 19, 2025 | 23:00:21
Category: News

North American Construction Group Ltd. Announces Results for the Fourth Quarter and Year Ended December 31, 2024

ACHESON, Alberta, March 19, 2025 ( GLOBE NEWSWIRE ) -- North American Construction Group Ltd. ( "NACG" ) ( TSX:NOA/NYSE:NOA ) today announced results for the fourth quarter and year ended December 31, 2024. Unless otherwise indicated, figures are expressed in Canadian dollars with comparisons to ...

Source: www.globenewswire.com
March 19, 2025 | 23:15:00
Category: News

Here's How Much $1000 Invested In Quanta Services 10 Years Ago Would Be Worth Today - Quanta Services ( NYSE:PWR )

Quanta Services PWR has outperformed the market over the past 10 years by 14.85% on an annualized basis producing an average annual return of 25.36%. Currently, Quanta Services has a market capitalization of $40.07 billion.

Source: www.benzinga.com
March 19, 2025 | 23:15:16
Category: News

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c ) ( 4 )

NOVATO, Calif., March 19, 2025 ( GLOBE NEWSWIRE ) -- Ultragenyx Pharmaceutical Inc. ( NASDAQ: RARE ) , a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 21,806 restricted stock units of the ...

Source: www.globenewswire.com
March 19, 2025 | 21:00:00
Category: News

© Natavest 2025 - 2026